Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
Hannes Vietzen(Medical University of Vienna), Elisabeth Puchhammer‐Stöckl(Medical University of Vienna), Philippe L. Furlano(Department of Virology), S. Berger(Department of Virology), Thomas Berger(Medical University of Vienna), Paulus Rommer(Medical University of Vienna), Laura M. Kühner(Department of Virology), Gabriel Bsteh(Medical University of Vienna)
Cited by 170
Related Papers
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Diagnosis and classification of optic neuritis
|The Lancet Neurology|2022|290
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
|Multiple Sclerosis and Related Disorders|2020|179
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
|New England Journal of Medicine|2024|151
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
|Multiple Sclerosis Journal|2008|141